SYROS PHARMACEUTICALS, INC. Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2023-09-14: Study NCT06085638; Company role Collaborator; Phase Phase 1, Phase 2; Status Withdrawn.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2023-09-14 | NCT06085638 Phase I/II Study of SY-1425 (Tamibarotene) in Combination With Azacitidine and Venetoclax for Patients With Chronic Myelomonocytic Leukemia | Collaborator Lead: M.D. Anderson Cancer Center | Phase 1, Phase 2 | Withdrawn | Chronic Myelomonocytic Leukemia | 0 | 2023-10-20 |